First Affiliated Hospital Of Chongqing Medical University

This study aims to see if adding a selenium supplement to standard depression medication (fluoxetine) helps reduce depression symptoms in teenagers aged 12-18. It will involve 172 participants who will be randomly assigned to receive either the supplement or a placebo (inactive p…

This study is testing a new three-drug combination for people with advanced liver cancer that initially responded to immunotherapy but has since started growing again. It aims to see if adding a new drug (Ivarmacitinib) to two existing ones can help control the cancer. The trial …

This study is testing whether a gentle, non-invasive brain stimulation device can help teenagers with their first episode of depression feel better faster when used alongside a standard medication. Thirty teens aged 12-18 will use the device for 20 sessions over 4 weeks to see if…

This is a small, early-stage study to test a faster version of a non-invasive brain stimulation treatment for teenagers with depression. Over 10 days, 45 participants will receive either real or sham stimulation to see if the real treatment is safe, acceptable, and shows signs of…

This study aims to see if new antibody drugs can better control severe flare-ups in people with Neuromyelitis Optica Spectrum Disorder (NMOSD), a rare disease where the immune system attacks nerves and eyes. It will follow about 40 patients in China for 6 months to compare the ef…

This small pilot study is testing whether a gentle, non-invasive brain stimulation device can help teens with depression feel better faster. Thirty teenagers who are already on stable depression medication will use the device or a fake version for 20 sessions over 4 weeks. Resear…

This study aims to understand the underlying biology of ureteral stricture, a condition that narrows the tube from the kidney to the bladder. Researchers will compare stool, urine, and blood samples from 120 people—some with the condition and some without—to see if differences in…